JP5424571B2 - トピラマート含有固形製剤 - Google Patents

トピラマート含有固形製剤 Download PDF

Info

Publication number
JP5424571B2
JP5424571B2 JP2008103209A JP2008103209A JP5424571B2 JP 5424571 B2 JP5424571 B2 JP 5424571B2 JP 2008103209 A JP2008103209 A JP 2008103209A JP 2008103209 A JP2008103209 A JP 2008103209A JP 5424571 B2 JP5424571 B2 JP 5424571B2
Authority
JP
Japan
Prior art keywords
topiramate
sodium
solid preparation
carmellose
additive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008103209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008280345A (ja
JP2008280345A5 (th
Inventor
直人 井沢
保博 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Priority to JP2008103209A priority Critical patent/JP5424571B2/ja
Publication of JP2008280345A publication Critical patent/JP2008280345A/ja
Publication of JP2008280345A5 publication Critical patent/JP2008280345A5/ja
Application granted granted Critical
Publication of JP5424571B2 publication Critical patent/JP5424571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2008103209A 2007-04-12 2008-04-11 トピラマート含有固形製剤 Active JP5424571B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008103209A JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007104853 2007-04-12
JP2007104853 2007-04-12
JP2008103209A JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013188248A Division JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤

Publications (3)

Publication Number Publication Date
JP2008280345A JP2008280345A (ja) 2008-11-20
JP2008280345A5 JP2008280345A5 (th) 2011-04-14
JP5424571B2 true JP5424571B2 (ja) 2014-02-26

Family

ID=40141447

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008103209A Active JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤
JP2013188248A Active JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤
JP2016207609A Pending JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013188248A Active JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤
JP2016207609A Pending JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Country Status (1)

Country Link
JP (3) JP5424571B2 (th)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
KR101931209B1 (ko) 2010-05-11 2018-12-20 얀센 파마슈티카 엔.브이. Sglt의 억제제로서 1-(베타-d-글루코피라노실)-2-티에닐-메틸벤젠 유도체를 포함하는 약학 제형
AU2012241897C1 (en) 2011-04-13 2017-05-11 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
IN2013MU02470A (th) * 2013-07-25 2015-06-26 Cadila Healthcare Ltd
CN108379588A (zh) * 2018-03-05 2018-08-10 合肥合源药业有限公司 托吡酯组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
EP1157682A1 (en) * 2000-05-25 2001-11-28 Cilag AG Blister package for topiramate tablets
DE10153078A1 (de) * 2001-10-30 2003-05-22 Degussa Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
EP1587499A1 (en) * 2003-01-31 2005-10-26 Elan Pharma International Limited Nanoparticulate topiramate formulations
EP1701708A2 (en) * 2003-12-29 2006-09-20 Alza Corporation Novel drug compositions and dosage forms of topiramate
EP1973528B1 (en) * 2006-11-17 2012-11-07 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
WO2008070670A2 (en) * 2006-12-04 2008-06-12 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate

Also Published As

Publication number Publication date
JP2008280345A (ja) 2008-11-20
JP6125957B2 (ja) 2017-05-10
JP2013241476A (ja) 2013-12-05
JP2017014289A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
JP2017014289A (ja) トピラマート含有固形製剤
EP2614816A1 (en) Granules containing bitter drug and orally disintegrating tablet
JP5750847B2 (ja) アトルバスタチン経口投与用粒子状医薬組成物
EP2229938B9 (en) Ezetimibe compositions
JP5798642B2 (ja) 経口用医薬組成物
JPWO2005097070A1 (ja) 安定性の向上した固形製剤およびその製造方法
KR20100121483A (ko) 용출성이 개선된 정제
JP6133009B2 (ja) トピラマート顆粒
CN101103965A (zh) 含有无定形头孢托仑酯的稳定固体制剂及其制备方法
AU2014225449B2 (en) Stabilization of moisture-sensitive drugs
JP6053425B2 (ja) ジベンゾ［ｂ，ｅ］オキセピン誘導体を含有する固形製剤
JP2012041293A (ja) 乳酸菌又はその抽出成分を含有する口腔内崩壊錠
US20070148245A1 (en) Compressed solid dosage forms with drugs of low solubility and process for making the same
Kestur et al. Excipients for conventional oral solid dosage forms
US20090048336A1 (en) Escitalopram oxalate powders
WO2013130584A2 (en) Formulation containing ws727713
JP4993274B2 (ja) フェノフィブラート含有製剤組成物の製造方法
JP2024076228A (ja) ニンテダニブエタンスルホン酸塩錠剤
JP2021070658A (ja) アビラテロン酢酸エステル含有製剤
JP2016098187A (ja) 口腔内崩壊錠
JP2023180494A (ja) ゾニサミド含有口腔内崩壊錠
JP2023038181A (ja) 酢酸亜鉛錠剤
JP2022047194A (ja) アキシチニブを有効成分とする医薬錠剤及びその製造方法
JP2021070659A (ja) アビラテロン酢酸エステル含有製剤
JP2013103924A (ja) 結晶性アトルバスタチンカルシウム含有錠剤の製造方法

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130122

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130325

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130611

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130911

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130924

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131120

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131126

R151 Written notification of patent or utility model registration

Ref document number: 5424571

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350